Richard Chin | Chief Executive Officer |
Wendy Wee | Chief Financial Officer |
Katja Buhrer | Vice President, Corporate Development and IR |
Jon Block | Stifel |
Balaji Prasad | Barclays |
Brandon Folkes | Cantor Fitzgerald |
David Westenberg | Guggenheim Securities |
Ben Haynor | Alliance Global Partners |
RK | H.C. Wainwright |
Nathan Weinstein | Aegis Capital |
Welcome to the Second Quarter 2020 Financial Results Conference Call and Webcast for Kindred Biosciences. At this time, all participants have been placed on a listen-only mode. At the end of the prepared statements, participants will have the opportunity to ask questions. Please note that the remarks today will include forward-looking statements and that actual results could differ materially from those projected or implied in our forward-looking statements.
For a description of important factors that could cause actual results to differ, we refer you to the forward-looking statements in today’s press release and the note on forward-looking statements in the company’s SEC filings.